期刊文献+

扶正固元法干预缺血性中风恢复期的疗效分析 被引量:3

The efficacy analysis of the approach of reinforce body resistance to consolidate vigor after intervening in ischemicstroke patients at their recovery stage
下载PDF
导出
摘要 目的评价扶正固元法干预缺血性中风恢复期的临床疗效。方法采用随机数字法将72例患者分别纳入至对照组与干预组。对照组采用西医常规治疗,干预组在对照组的治疗基础上加服扶正固元方,2W为一个疗程,连续服用2个疗程。治疗前后分别观察NIHSS评分、Barthel指数、MRS、神经功能缺损积分疗效分级评定以及中医症状记分和综合疗效指数与缺血性中风发病相关因素相关性的判定。结果与对照组2W后、3m后分别进行比较,干预组NIHSS评分与MRS降低、Barthel指数与中医症状记分增高,均具有统计学意义(P〈0.01);按照神经功能缺损积分疗效评定分级标准进行分级,干预组较对照组显愈率与有效率显著提高(P〈O.01);且经统计分析,疗效指数与年龄、伴发病积分、既往史积分呈负相关,与病程、中医证候疗效指数无相关性关系。结论扶正固元方具有能够改善缺血性中风恢复期患者临床症状,提高日常生活活动能力的作用,临床疗效得以提高。 Objective To evaluate the clinic efficacy of the approach of reinforce body resistance to consolidate vigor after intervening in ischemic stroke patients at their recovery stage. Methods 72 patients were randomly divided into an in- tervention group and a control group. Both groups were given basic treatment. At this basis, the patients in the intervention group were given Chinese decoction, namely prescription for reinforcing body resistance to consolidate vigor for two courses of treatment. One course consists of two weeks. The scores of NIHSS, Barthel index, MRS, Classification efficacy assessment of neurological deficit scores, and the correlation judgments between the TCM symptom scores, comprehensive efficacy index and the factors related to ischemic stroke patients were assessed before treatment, after 2 weeks, and 3 months admission of the trial, respectively. Results Compare with the control group after 2 weeks' and 3 months' inter- vention, the NIHSS and MRS were decreased, while the BI index and the symptom score of TCM were increased in the intervention group, and both display the statistical significance (P〈0.01). According to the classification of efficacy as- sessment of neurological deficit scores, the obvious curative rate and curative efficacy in the intervention group were higher than those in the control group, and they still appear statistical significance (P〈0.01). Through statistical analysis, the efficacy index has negative correlation with the score of concomitant disease, the past history and age, while it has no cor- relation with the course of disease and the efficacy index of TCM symptom. Conclusions The prescription for reinforce body resistance to consolidate vigor could improve the clinical symptoms and activities of daily living of the ischemic stroke patients, and consequently the clinic efficacy was increased.
出处 《老年医学与保健》 CAS 2013年第6期397-401,共5页 Geriatrics & Health Care
关键词 缺血性中风 恢复期 扶正固元法 Ischemic stroke Recovery stage Reinforce body resistance to consolidate vigor
  • 相关文献

参考文献6

二级参考文献12

  • 1魏江磊.中风先兆症候的性别年龄及证型特征考辨[J].中医药学刊,2004,22(9):1603-1605. 被引量:16
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33037
  • 3王新志,韩群英,陈贺华.脑血管病的流行特点-脑血管病家庭史[M]//中华实用中风病大全.北京:人民卫生出版社,1996:16.
  • 4王新志,韩群英,陈贺华.脑血管病的流特点-患病率-发病率[M]//中华实用中风病大全.北京:人民卫生出版社,1996:14.
  • 5Jade W. Wei, Ji - Guang Wang, Yining Huang, et al. Secondary Pre- vention of Ischemic Stroke in Urban China [ J ]. Stroke, 2010 ( 5 ) : 967 - 974.
  • 6Albers GW,Amarenco P,Easton JD,et al. Antithrombotic and throm- bolytic therapy for ischemic stroke: American College nf Chest Physi- cians Evidence - Based Clinical Practice Guidelines (8th edition) [ J ]. Chest ,2008,133:630 - 669.
  • 7Albers GW,Amarenco P, Easton JD, et al. Antithrombotic and throm- bolytic therapy for ischemic stroke: the seventh ACCP confrence on antithrombotic and thrombolytie therapy [ J ]. Chest, 2004,126 : 483 - 512.
  • 8袁园,过伟峰.浅谈中医论治中风病的源流[J].辽宁中医药大学学报,2009,11(8):15-16. 被引量:6
  • 9朱哲.中风病机演变规律的初步探讨[J].辽宁中医药大学学报,2009,11(9):9-10. 被引量:4
  • 10曹志娟,张建荣.中风溯源[J].辽宁中医药大学学报,2009,11(12):33-34. 被引量:2

共引文献42955

同被引文献20

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部